"Difficult" pneumonia

"Difficult" pneumonia

The article considers the issues of therapeutic management of patients with so-called difficult pneumonia, particularly, patients with diagnosed syndrome slowly resolving / nonresolving pneumonia, who do not respond to the treatment. The reasons and significant risk factors potentially affecting the...

Full description

Bibliographic Details
Main Authors:	Andrey A. Zaicev, Alexander I. Sinopalnikov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2021-03-01
Series:	Терапевтический архив
Subjects:	community-acquired pneumonia “non-responding” pneumonia slowly resolving pneumonia antibiotic therapy
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/64974/47827

Similar Items

Short antibiotic courses in community-acquired pneumonia in adults: less is better
by: A. I. Sinopalnikov
Published: (2018-10-01)

PLACE OF RESPIRATORY FLUOROQUINOLONES IN THERAPY OF COMMUNITY ACQUIRED PNEUMONIA: FOCUS ON HIGH-DOSE LEVOFLOXACINE THERAPEUTIC REGIME
by: A. I. Sinopalnikov
Published: (2017-11-01)

Bronchoscopic Microbial Diagnosis in Non-Responding & Non-Resolving Pneumonia
by: Muhammad Saqib, et al.
Published: (2021-01-01)

The effect of taking antibacterial therapy on the outpatient stage and outcomes of community-acquired pneumonia in Tomsk hospitals
by: Daria A. Vinokurova, et al.
Published: (2024-01-01)

Pneumonia in nursing home patients: is it time for a specific therapeutic strategy?
by: Gualberto Gussoni, et al.
Published: (2013-04-01)

Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)

Community-acquired pneumonia in adults: Approaches to antibacterial therapy in the context of current clinical guidelines
by: A I Sinopalnikov
Published: (2010-08-01)

Bacterial Isolates in Slow Resolving Pneumonias
by: Abdul Rasheed Qureshi, et al.
Published: (2019-05-01)

The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019–2020
by: Cheng-Yen Kuo, et al.
Published: (2022-08-01)

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia
by: Mansoreh Momen Heravi, et al.
Published: (2023-12-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Delayed diagnosis of pneumonia in the emergency department: factors associated and prognosis
by: Maria Bouam, et al.
Published: (2023-05-01)

The real life application of a procalcitonin-based algorithm to reduce antibiotic exposure in hospitalized patients with community acquired pneumonia: a proof of concept
by: Filippo Pieralli, et al.
Published: (2016-09-01)

PROBLEMS OF ANTIBIOTIC THERAPY IN KOVID-ASSOCIATED HOSPITAL PNEUMONIA
by: O.A. Savchenko, et al.
Published: (2022-06-01)

Case of severe Friedlander′s pneumonia with review of the literature
by: Prasanna K Satpathy, et al.
Published: (2014-01-01)

Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators
by: Catia Cillóniz, et al.
Published: (2020-01-01)

Antibiotic resistance of Streptococcus pneumoniae in Vietnamese children with severe pneumonia: a cross-sectional study
by: Khai Tran-Quang, et al.
Published: (2023-06-01)

Guidelines and management of hospitalized patients with community-acquired pneumonia: the Italian experience of the FASTCAP study
by: I. Iori, et al.
Published: (2013-05-01)

A Rare Case of Non-resolving Pneumonia: Lipoid Pneumonia
by: Bilge Yılmaz Kara, et al.
Published: (2020-01-01)

chlamydia pneumoniae unfection in - patients with community acquired pneumonia in Iraq
by: hayfaa D. Salman
Published: (2009-01-01)

Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population
by: Sanath Thushara Kudagammana, et al.
Published: (2020-08-01)

Community-acquired pneumonia /
by: Suttorp, N. (Norbert), 1953-, et al.
Published: (2007)

Clarithromycin for community-acquired pneumonia in adults: focus on anti-inflammatory properties
by: Alexander I. Sinopalnikov, et al.
Published: (2023-01-01)

Community-Acquired Pneumonia in Children: Current Approaches to the Duration of Antibiotic Therapy
by: S.O. Mokiia-Serbina, et al.
Published: (2016-03-01)

Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain
by: Ana Dacosta Urbieta, et al.
Published: (2024-12-01)

Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
by: Sinopalnikov A.I., et al.
Published: (2019-12-01)

Antibiotic therapy of choice for community-acquired pneumonia in Malaysian Hajj pilgrims: the pattern and associated factors
by: Diana Dzaraly, et al.
Published: (2017-09-01)

PES Pathogens in Severe Community-Acquired Pneumonia
by: Catia Cillóniz, et al.
Published: (2019-02-01)

Investigation of Viral and Atypical Pathogens in Patients with Pneumonia Who Need Intensive Care Unit
by: Ahmet DOĞAN, et al.
Published: (2022-03-01)

Predictors of hospital mortality and multidrug-resistant pathogens in hospitalized pneumonia patients residing in the community
by: Tomohiko Ukai, et al.
Published: (2023-12-01)

Community-acquired pneumonia in hospitalized patients: clinical guidelines
by: A. A. Zaytsev, et al.
Published: (2019-12-01)

Influence of antibiotics of different groups on the course of community-acquired pneumonia in children
by: N.Yu. Shcherbatiuk, et al.
Published: (2022-12-01)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
by: Catia Cillóniz, et al.
Published: (2018-04-01)

Características clínicas y epidemiológicas de las neumonías adquiridas en la comunidad por Mycoplasma pneumoniae en una población española, 2010-2015
by: David Aguilera-Alonso, et al.
Published: (2019-07-01)

Effectiveness of 3rd generation cephalosporin compare to 3rd generation cephalosporin - macrolides for community acquired pneumonia patients in PKU Muhammadiyah Yogyakarta Hospital
by: Muhammad Dwi Suprobo, et al.
Published: (2019-11-01)

DIAGNOSTIC VALUE OF PROCALCITONIN, C-REACTIVE PROTEIN AND TRANS-RESONANT FUNCTIONAL TOPOGRAPHY IN THE COURSE OF COMMUNITY-ACQUIRED PNEUMONIA
by: A.V. Konkov, et al.
Published: (2008-09-01)

Dilemma of community-acquired pneumonia
by: Lamia H Shaaban
Published: (2019-01-01)

Rapid diagnosis of community-acquired pneumonia using the Bac T/ alert 3D system
by: Malini R. Capoor, et al.

Evaluation of a Pediatric Community-Acquired Pneumonia Antimicrobial Stewardship Intervention at an Academic Medical Center
by: Lauren Puzz, et al.
Published: (2023-04-01)

Fatal Community-Acquired Pneumonia: 18 Years in a Medical Center
by: Ling-Jen Wang, et al.
Published: (2013-02-01)